131 related articles for article (PubMed ID: 35201451)
21. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MEG3 promotes proliferation and differentiation of osteoblasts through Wnt/β-catenin signaling pathway.
Li XG; Liu SC; Qiao XF; Kong Y; Liu JG; Peng XM; Wang YX; Abdulkarim Mohammed Al-Mohana RA
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4521-4529. PubMed ID: 31210279
[TBL] [Abstract][Full Text] [Related]
24. lncRNA mortal obligate RNA transcript was downregulated in ovarian carcinoma and inhibits cancer cell proliferation by downregulating miRNA-21.
Chen X; Wu W; Cao X; Zhao X; Li W; Deng C; Huang Z
J Cell Biochem; 2019 Jul; 120(7):11949-11954. PubMed ID: 30916806
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.
Han K; Wang FR; Yu MQ; Xu B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5242-5248. PubMed ID: 32495857
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein.
Yang Z; Wang Z; Duan Y
Oncol Lett; 2020 Sep; 20(3):2183-2190. PubMed ID: 32782535
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the Proliferation/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a/Smad1 Axis.
Bai Y; Zhang Q; Su Y; Pu Z; Li K
Int Heart J; 2019 Mar; 60(2):444-450. PubMed ID: 30745534
[TBL] [Abstract][Full Text] [Related]
28. Linc-POU3F3 is overexpressed in hepatocellular carcinoma and regulates cell proliferation, migration and invasion.
Li Y; Li Y; Wang D; Meng Q
Biomed Pharmacother; 2018 Sep; 105():683-689. PubMed ID: 29906746
[TBL] [Abstract][Full Text] [Related]
29. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
Wei GH; Wang X
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3850-3856. PubMed ID: 28975980
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MEG3 induces cell apoptosis in esophageal cancer through endoplasmic reticulum stress.
Huang ZL; Chen RP; Zhou XT; Zhan HL; Hu MM; Liu B; Wu GD; Wu LF
Oncol Rep; 2017 May; 37(5):3093-3099. PubMed ID: 28405686
[TBL] [Abstract][Full Text] [Related]
32. Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs.
Tong Y; Yang L; Yu C; Zhu W; Zhou X; Xiong Y; Wang W; Ji F; He D; Cao X
Mol Ther Oncolytics; 2020 Sep; 18():1-13. PubMed ID: 32637576
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.
Liu Z; Wu C; Xie N; Wang P
Oncol Lett; 2017 Oct; 14(4):4053-4058. PubMed ID: 28959364
[TBL] [Abstract][Full Text] [Related]
34. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
35. LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies.
Zhang Y; Liu J; Lv Y; Zhang C; Guo S
Am J Transl Res; 2019; 11(7):4089-4099. PubMed ID: 31396320
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
Tan J; Xiang L; Xu G
IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
[TBL] [Abstract][Full Text] [Related]
37. UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis.
Huang ZF; Tang YL; Shen ZL; Yang KY; Gao K
Mol Ther Oncolytics; 2022 Mar; 24():497-506. PubMed ID: 35229028
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MEG3 regulates CSE-induced apoptosis and inflammation via regulating miR-218 in 16HBE cells.
Song B; Ye L; Wu S; Jing Z
Biochem Biophys Res Commun; 2020 Jan; 521(2):368-374. PubMed ID: 31668807
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MORT overexpression inhibits cancer cell proliferation in oral squamous cell carcinoma by downregulating ROCK1.
Jin Z; Jiang S; Jian S; Shang Z
J Cell Biochem; 2019 Jul; 120(7):11702-11707. PubMed ID: 30805944
[TBL] [Abstract][Full Text] [Related]
40. Maternally expressed 3 inhibits the biological activity of oral squamous cell carcinoma SCC25 and CAL27 cell lines.
Wang W; Li H; Qiu Y; Li K; Lu Y; Deng Q; Liu T
Oncol Lett; 2021 Nov; 22(5):784. PubMed ID: 34594425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
